A novel, evolutionarily conserved protein phosphatase complex involved in cisplatin sensitivity

Molecular and Cellular Proteomics

Volumn 4, Issue 11, 2005, Pages 1725-1740

  Gingras, Anne Claude ^a   Caballero, Michael ^b   Zarske, Marcel ^b   Sanchez, Amy ^a   Hazbun, Tony R ^c   Fields, Stanley ^c   Sonenberg, Nahum ^d   Hafen, Ernst ^b   Raught, Brian ^a   Aebersold, Ruedi ^a,b,e  

^a INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d MCGILL UNIVERSITY   (Canada)

^e ETH ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; CISPLATIN; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN PP4R3; SACCHAROMYCES CEREVISIAE PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; DNA DAMAGE; DNA REPAIR; DROSOPHILA MELANOGASTER; DRUG HYPERSENSITIVITY; EUKARYOTE; FUNGAL STRAIN; GENETIC CONSERVATION; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION;

DROSOPHILA MELANOGASTER; EUKARYOTA; SACCHAROMYCES CEREVISIAE;

EID: 28644433887     PISSN: 15359476     EISSN: None     Source Type: Journal    
DOI: 10.1074/mcp.M500231-MCP200     Document Type: Article

References (52)

1. Barford, D., Das, A. K., and Egloff, M. P. (1998) The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu. Rev. Biophys. Biomol. Struct. 27, 133-164
2. Andreeva, A. V., and Kutuzov, M. A. (2001) PPP family of protein Ser/Thr phosphatases: two distinct branches? Mol. Biol. Evol. 18, 448-452
3. Cohen, P. T. (1997) Novel protein serine/threonine phosphatases: variety is the spice of life. Trends Biochem. Sci. 22, 245-251
4. Janssens, V., Goris, J., and Van Hoof, C. (2005) PP2A: the expected tumor suppressor. Curr. Opin. Genet. Dev. 15, 34-41
5. Sontag, E. (2001) Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell. Signal. 13, 7-16
6. Kloeker, S., and Wadzinski, B. E. (1999) Purification and identification of a novel subunit of protein serine/threonine phosphatase 4. J. Biol. Chem. 274, 5339-5347
7. Hastie, C. J., Carnegie, G. K., Morrice, N., and Cohen, P. T. (2000) A novel 50 kDa protein forms complexes with protein phosphatase 4 and is located at centrosomal microtubule organizing centres. Biochem. J. 347, 845-855
8. Carnegie, G. K., Sleeman, J. E., Morrice, N., Hastie, C. J., Peggie, M. W., Philp, A., Lamond, A. I., and Cohen, P. T. (2003) Protein phosphatase 4 interacts with the Survival of Motor Neurons complex and enhances the temporal localisation of snRNPs. J. Cell Sci. 116, 1905-1913
9. Zhang, X., Ozawa, Y., Lee, H., Wen, Y. D., Tan, T. H., Wadzinski, B. E., and Seto, E. (2005) Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. Genes Dev. 19, 827-839
10. Wu, H. I., Brown, J. A., Dorie, M. J., Lazzeroni, L., and Brown, J. M. (2004) Genome-wide identification of genes conferring resistance to the anti-cancer agents cisplatin, oxaliplatin, and mitomycin C. Cancer Res. 64, 3940-3948
11. Siddik, Z. H. (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22, 7265-7279
12. Wang, D., and Lippard, S. J. (2005) Cellular processing of platinum anti-cancer drugs. Nat. Rev. Drug Discov. 4, 307-320
13. Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P., Qureshi-Emili, A., Li Y., Godwin, B., Conover, D., Kalbfleisch, T., Vijayadamodar, G., Yang, M., Johnston, M., Fields, S., and Rothberg, J. M. (2000) A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403, 623-627
14. Hazbun, T. R., and Miller, J. P. (2005) Genome-wide analysis of protein-protein interactions by a two-hybrid assay, in Protein-Protein Interactions, a Molecular Cloning Manual, Cold Spring Harbor Press, Cold Spring Harbor, NY, in press
15. Tasto, J. J., Carnahan, R. H., McDonald, W. H., and Gould, K. L. (2001) Vectors and gene targeting modules for tandem affinity purification in Schizosaccharomyces pombe. Yeast 18, 657-662
16. Rigaut, G., Shevchenko, A., Rutz, B., Wilm, M., Mann, M., and Seraphin, B. (1999) A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 17, 1030-1032
17. Pedrioli, P. G., Eng, J. K., Hubley, R., Vogelzang, M., Deutsch, E. W., Raught, B., Pratt, B., Nilsson, E., Angeletti, R. H., Apweiler, R., Cheung, K., Costello, C. E., Hermjakob, H., Huang, S., Julian, R. K., Kapp, E., McComb, M. E., Oliver, S. G., Omenn, G., Paton, N. W., Simpson, R., Smith, R., Taylor, C. F., Zhu, W., and Aebersold, R. (2004) A common open representation of mass spectrometry data and its application to proteomics research. Nat. Biotechnol. 22, 1459-1466
18. Han, D. K., Eng, J., Zhou, H., and Aebersold, R. (2001) Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat. Biotechnol. 19, 946-951
19. Keller, A., Nesvizhskii, A. I., Kolker, E., and Aebersold, R. (2002) Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 74, 5383-5392
20. Nesvizhskii, A. I., Keller, A., Kolker, E., and Aebersold, R. (2003) A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658
21. Gingras, A. C., Aebersold, R., and Raught, B. (2005) Advances in protein complex analysis using mass spectrometry. J. Physiol. 563, 11-21
22. Puig, O., Caspary, F., Rigaut, G., Rutz, B., Bouveret, E., Bragado-Nilsson, E., Wilm, M., and Seraphin, B. (2001) The tandem affinity purification (TAP) method: a general procedure of protein complex purification. Methods 24, 218-229
23. Gomez-Puertas, P., Martin-Benito, J., Carrascosa, J. L., Willison, K. R., and Valpuesta, J. M. (2004) The substrate recognition mechanisms in chaperonins. J. Mol. Recognit. 17, 85-94
24. Chen, J., Peterson, R. T., and Schreiber, S. L. (1998) Alpha4 associates with protein phosphatases 2A, 4, and 6. Biochem. Biophys. Res. Commun. 247, 827-832
25. Duvel, K., and Broach, J. R. (2004) The role of phosphatases in TOR signaling in yeast. Curr. Top. Microbiol. Immunol. 279, 19-38
26. Di Como, C. J., and Arndt, K. T. (1996) Nutrients, via the Tor proteins, stimulate the association of Tap42 with type 2A phosphatases. Genes Dev. 10, 1904-1916
27. Murata, K., Wu, J., and Brautigan, D. L. (1997) B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc. Natl. Acad. Sci. U. S. A. 94, 10624-10629
28. Nanahoshi, M., Nishiuma, T., Tsujishita, Y., Hara, K., Inui, S., Sakaguchi, N., and Yonezawa, K. (1998) Regulation of protein phosphatase 2A catalytic activity by alpha4 protein and its yeast homolog Tap42. Biochem. Biophys. Res. Commun. 251, 520-526
29. Ho, Y., Gruhler, A., Heilbut, A., Bader, G. D., Moore, L., Adams, S. L., Millar, A., Taylor, P., Bennett, K., Boutilier, K., Yang, L., Wolting, C., Donaldson, I., Schandorff, S., Shewnarane, J., Vo, M., Taggart, J., Goudreault, M., Muskat, B., Alfarano, C., Dewar, D., Lin, Z., Michalickova, K., Willems, A. R., Sassi, H., Nielsen, P. A., Rasmussen, K. J., Andersen, J. R., Johansen, L. E., Hansen, L. H., Jespersen, H., Podtelejnikov, A., Nielsen, E., Crawford, J., Poulsen, V., Sorensen, B. D., Matthiesen, J., Hendrickson, R. C., Gleeson, F., Pawson, T., Moran, M. F., Durocher, D., Mann, M., Hogue, C. W., Figeys, D., and Tyers, M. (2002) Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415, 180-183
30. Kelley, L. A., MacCallum, R. M., and Sternberg, M. J. (2000) Enhanced genome annotation using structural profiles in the program 3D-PSSM. J. Mol. Biol. 299, 499-520
31. Kittler, R., Putz, G., Pelletier, L., Poser, I., Heninger, A. K., Drechsel, D., Fischer, S., Konstantinova, I., Habermann, B., Grabner, H., Yaspo, M. L., Himmelbauer, H., Korn, B., Neugebauer, K., Pisabarro, M. T., and Buchholz, F. (2004) An endoribonuclease-prepared siRNA screen in human cells identifies genes essential for cell division. Nature 432, 1036-1040
32. Zarske, M., and Hafen, E. (2003) Falafel, a novel EVH1 domain protein involved in Rac mediated epithelial morphogenesis, in 44th Annual Drosophila Research Conference, Chicago, March 5-9, 2003, The Genetics Society of America, Bethesda, MD
33. Jacinto, E., Guo, B., Arndt, K. T., Schmelzle, T., and Hall, M. N. (2001) TIP41 interacts with TAP42 and negatively regulates the TOR signaling pathway. Mol. Cell 8, 1017-1026
34. Kloeker, S., Bryant, J. C., Strack, S., Colbran, R. J., and Wadzinski, B. E. (1997) Carboxymethylation of nuclear protein serine/threonine phosphatase X. Biochem. J. 327, 481-486
35. Ito, T., Chiba, T., Ozawa, R., Yoshida, M., Hattori, M., and Sakaki, Y. (2001) A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc. Natl. Acad. Sci. U. S. A. 98, 4569-4574
36. Li, X., and Virshup, D. M. (2002) Two conserved domains in regulatory B subunits mediate binding to the A subunit of protein phosphatase 2A. Eur. J. Biochem. 269, 546-552
37. Gavin, A. C. Bosche, M., Krause, R., Grandi, P., Marzioch, M., Bauer, A., Schultz, J., Rick, J. M., Michon, A. M., Cruciat, C. M., Remor, M., Hofert, C., Schelder, M., Brajenovic, M., Ruffner, H., Merino, A., Klein, K., Hudak, M., Dickson, D., Rudi, T., Gnau, V., Bauch, A., Bastuck, S., Huhse, B., Leutwein, C., Heurtier, M. A., Copley, R. R., Edelmann, A., Querfurth, E., Rybin, V., Drewes, G., Raida, M., Bouwmeester, T., Bork, P., Seraphin, B., Kuster, B., Neubauer, G., and Superti-Furga, G. (2002) Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415, 141-147
38. Hanway, D., Chin, J. K., Xia, G., Oshiro, G., Winzeler, E. A., and Romesberg, F. E. (2002) Previously uncharacterized genes in the UV- and MMS-induced DNA damage response in yeast. Proc. Natl. Acad. Sci. U. S. A. 99, 10605-10610
39. Jansen, L. E., Belo, A. I., Hulsker, R., and Brouwer, J. (2002) Transcription elongation factor Spt4 mediates loss of phosphorylated RNA polymerase II transcription in response to DNA damage. Nucleic Acids Res. 30, 3532-3539
40. Motoyama, N., and Naka, K. (2004) DNA damage tumor suppressor genes and genomic instability. Curr. Opin. Genet. Dev. 14, 11-16
41. Quivy, J. P., and Almouzni, G. (2003) Rad53: a controller ensuring the fine-tuning of histone levels. Cell 115, 508-510
42. O'Neill, B. M., Hanway, D., Winzeler, E. A., and Romesberg, F. E. (2004) Coordinated functions of WSS1, PSY2 and TOF1 in the DNA damage response. Nucleic Acids Res. 32, 6519-6530
43. Yeh, P. Y., Yeh, K. H., Chuang, S. E., Song, Y. C., and Cheng, A. L. (2004) Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-κB activation by protein phosphatase 4-mediated NF-κB p65 Thr dephosphorylation. J. Biol. Chem. 279, 26143-26148
44. Jamieson, E.R., and Lippard, S.J. (1999) Structure, recognition, and processing of cisplatin-DNA adducts. Chem. Rev. 99, 2467-2498
45. Ho, Y. P., Au-Yeung, S. C., and To, K. K. (2003) Platinum-based anticancer agents: innovative design strategies and biological perspectives. Med. Res. Rev. 23, 633-655
46. To, K. K., Ho, Y. P., and Au-Yeung, S. C. (2005) Synergistic interaction between platinum-based antitumor agents and demethylcantharidin. Cancer Lett. 223, 227-237
47. To, K. K., Wang, X., Yu, C. W., Ho, Y. P., and Au-Yeung, S. C. (2004) Protein phosphatase 2A inhibition and circumvention of cisplatin cross-resistance by novel TCM-platinum anticancer agents containing demethylcantharidin. Bioorg. Med. Chem. 12, 4565-4573
48. Hastie, C. J., and Cohen, P. T. (1998) Purification of protein phosphatase 4 catalytic subunit: inhibition by the antitumour drug fostriecin and other tumour suppressors and promoters. FEBS Lett. 431, 357-361
49. Shi, Y., Frankel, A., Radvanyi, L. G., Penn, L. Z., Miller, R. G., and Mills, G. B. (1995) Rapamycin enhances apoptosis and increases sensitivity to cisplatin in vitro. Cancer Res. 55, 1982-1988
50. Hay, N., and Sonenberg, N. (2004) Upstream and downstream of mTOR. Genes Dev. 18, 1926-1945
51. Vignot, S., Faivre, S., Aguirre, D., and Raymond, E. (2005) mTOR-targeted therapy of cancer with rapamycin derivatives. Ann. Oncol. 16, 525-537
52. Beuvink, I., Boulay, A., Fumagalli, S., Zilbermann, F., Ruetz, S., O'Reilly, T., Natt, F., Hall, J., Lane, H. A., and Thomas, G. (2005) The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation. Cell 120, 747-759